Welcome to our dedicated page for Trulieve Cannabis news (Ticker: TCNNF), a resource for investors and traders seeking the latest updates and insights on Trulieve Cannabis stock.
Trulieve Cannabis Corp. (TCNNF) generates frequent news across operations, finance, regulation, and product development, reflecting its role as a vertically integrated, multi-state cannabis operator. As an industry leading company with leading market positions in Arizona, Florida, and Pennsylvania, Trulieve’s announcements often cover expansion of its retail footprint, capital markets activity, and responses to evolving cannabis policy in the United States.
Investors and observers following Trulieve news will see regular updates on financial performance, such as quarterly results detailing revenue, gross margin, cash flow, and non-GAAP metrics like adjusted EBITDA and free cash flow. The company also issues press releases about conference calls and investor presentations, providing context on its operating strategy, retail network, and production capacity.
Trulieve’s news flow includes financing developments, such as private placements of senior secured notes, redemptions of existing debt, and related SEC filings. These items outline interest rates, maturities, security pledges, and intended use of proceeds for capital expenditures and general corporate purposes. Such updates are important for understanding the company’s capital structure and liquidity.
Operational news highlights new dispensary openings, licensing agreements, and market entries. For example, Trulieve has announced Trulieve-branded dispensaries in Ohio operated by a partner under license, as well as conditional approval for a Dispensing Organization license under the Texas Compassionate Use Program. Product-focused releases showcase new offerings, including additional flavors of Onward and Upward THC-infused beverages and other branded cannabis products.
Policy and regulatory developments also feature in Trulieve’s news, including its public support for marijuana rescheduling to Schedule III under the Controlled Substances Act. For users tracking TCNNF, this news page offers a centralized view of the company’s financial updates, expansion moves, product launches, and regulatory commentary over time.
Trulieve Cannabis Corp. announced the opening of a new medical dispensary in Coral Springs, Florida, on July 1, 2022. This facility will operate seven days a week, enhancing patient access to medical cannabis. The grand opening features various festivities and a 25% discount for all registered patients. Trulieve emphasizes its commitment to quality products and personalized patient care, offering a wide range of THC and CBD products. The company operates in 11 states and is a leading cannabis provider with a focus on expanding access and customer experience.
Trulieve Cannabis Corp. held its Annual Meeting of Shareholders on June 8, 2022, where resolutions were approved to elect eight directors and reappoint Marcum LLP as auditors. A total of 97,288,636 votes were cast, representing 52.8% of outstanding shares. The elected directors are Kim Rivers, Giannella Alvarez, Thad Beshears, Peter Healy, Richard May, Thomas Millner, Jane Morreau, and Susan Thronson. The company, operating in 11 states and a leading cannabis operator, aims for growth and market expansion.
Summary not available.
Trulieve Cannabis Corp. (OTCQX: TCNNF) announces its participation in several upcoming conferences in June 2022. Key events include the 19th Annual Craig-Hallum Institutional Investor Conference on June 1, the Jefferies Cannabis Summit on June 2 in New York, an Analyst Event with a bus tour in Florida on June 7, and the Annual Shareholder Meeting on June 8, accessible online. Trulieve, a leading cannabis company operating in 11 states, is focused on growth through its hub strategy and aims to provide high-quality products to enhance customer experience.
Summary not available.
Trulieve Cannabis Corp. (OTCQX: TCNNF) reported record revenue of $318.3 million for Q1 2022, marking a 64% increase year-over-year and a 4% rise sequentially. The gross profit reached $178.2 million with a gross margin of 56%. Despite a net loss of $32.0 million, adjusted net income was $1.7 million. Operationally, Trulieve has an extensive retail network with 165 dispensaries and over 4.0 million square feet of cultivation capacity. The company expects 2022 revenue between $1.3 billion and $1.4 billion.
Trulieve Cannabis Corp. (CSE: TRUL; OTCQX: TCNNF) announced its participation in May 2022 events, highlighting a keynote speech by CEO Kim Rivers at Regenerative Cannabis Live on May 5, 2022. Trulieve is a leading, vertically integrated cannabis company operating in 11 states, focusing on growth and market expansion through its hub strategy. The company aims to provide innovative, high-quality products to enhance customer experiences and access to cannabis.
On April 28, 2022, Trulieve Cannabis Corp. announced that CEO Kim Rivers received the Women's Leadership Award from Green Market Report for her contributions in the cannabis industry. Rivers has driven significant business advancements, including leading retail expansion and the acquisition of Harvest Health. Trulieve also released its first ESG report, marking a milestone in corporate responsibility. The award ceremony took place during the Women's Summit in New York City, highlighting the importance of female leadership in the cannabis sector.
Trulieve Cannabis Corp. (OTCQX: TCNNF) announced the completion of its acquisition of Greenhouse Wellness West Virginia Dispensaries LLC, which holds a dispensary permit in West Virginia. The acquisition, covered by the West Virginia Department of Health and Human Resources, involved a minimal cash payment. This deal enhances Trulieve's presence in West Virginia, where it now operates ten dispensaries in key locations and plans to open more in the near future. CEO Kim Rivers emphasized the company's commitment to community investment and improved patient access to high-quality products.
Summary not available.